Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
908 DevicesMASS +0.10%69 3-Year EPS without NRI Growth Rate is 20.00% as of Jun. 2026, which is 1233% above its 10-year median of 1.50. GuruFocus rates MASS with a GF Score™ of 69/100 and a GF Value™ of $7.11 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 662 Medical Devices & Instruments companies, 908 Devices ranks better than 65.86% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 20.00% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 19.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 8 years, the highest 3-Year average EPS without NRI Growth Rate of 908 Devices was 21.70% per year. The lowest was -25.40% per year. And the median was 1.50% per year.
908 Devices (NAS:MASS) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
908 Devices 3-Year EPS without NRI Growth Rate Related Terms
MASS vs SI, PACB, SGHT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, 908 Devices's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where 908 Devices's 3-Year EPS without NRI Growth Rate falls into.
908 Devices 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 20.00% mean?
908 Devices (MASS) has a 3-Year EPS without NRI Growth Rate of 20.00% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for 908 Devices and its competitors. This is 1233% above median its historical median of 1.50. According to the industry distribution chart, 908 Devices ranks #226 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 34.1%.
Is 908 Devices' 3-Year EPS without NRI Growth Rate too high?
908 Devices' current 3-Year EPS without NRI Growth Rate of 20.00% is 1233% above median its 10-year median of 1.50. The Medical Devices & Instruments industry median 3-Year EPS without NRI Growth Rate is 7.90. 908 Devices' value of 20.00% is 153.2% above this industry median. Based on the distribution chart, 908 Devices ranks #226 out of 662 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, 908 Devices has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' 3-Year EPS without NRI Growth Rate compare to SI and PACB?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #226 out of 662 companies for 3-Year EPS without NRI Growth Rate. This puts 908 Devices in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 7.90. 908 Devices' value of 20.00% is 153.2% above this benchmark. While the company's 10-year median is 1.50 vs. the industry median of 7.90, 908 Devices has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 7.90, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current 3-Year EPS without NRI Growth Rate of 20.00% is 153.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current 3-Year EPS without NRI Growth Rate is 20.00%, which is 1233% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Significantly Overvalued. The stock's GF Value™ is $7.11, compared to a current price of $10.05 — trading 41.4% above its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 20.00%, which is 1233% above median its 10-year median of 1.50 and 153.2% above the Medical Devices & Instruments industry median of 7.90. 908 Devices' overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For 908 Devices (MASS), the current 3-Year EPS without NRI Growth Rate is 20.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $10.05 is trading 41.4% above its estimated GF Value™ of $7.11.
GuruFocus considers 908 Devices to be Significantly Overvalued.
Key valuation signals for MASS:
3-Year EPS without NRI Growth Rate: 20.00% (1233% above median its 10-year median of 1.50)
GF Value™: $7.11 vs. price of $10.05 (41.4% above fair value)
Industry Position: 153.2% above the Medical Devices & Instruments median (#226 of 662)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
69GF Score
Get the complete analysis for MASS
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
